Menopausal hormone therapy reduces the risk of fracture regardless of falls risk or baseline FRAX probability-results from the Women’s Health Initiative hormone therapy trials

By sjmartinez • July 14, 2022

Lorentzon M, Johansson H, Harvey NC, Liu E, Vandenput L, Crandall CJ, Cauley JA, LeBoff MS, McCloskey EV, Kanis JA. Menopausal hormone therapy reduces the risk of fracture regardless of falls risk or baseline FRAX probability-results from the Women's Health Initiative hormone therapy trials. Osteoporos Int. 2022 Jul 14. doi: 10.1007/s00198-022-06483-y. Epub ahead of print. PMID: 35833956.

Tags: Epidemiology, Falls, Fracture risk, FRAX, Infectious Diseases, Menopausal hormone therapy, Osteoporosis, Postmenopausal women, Publications

Leveraging a large language model to support expansion of surveillance activities to include cardiovascular implantable device infections in a large, integrated national healthcare system

Basnet D, Mull HJ, Morgan DJ, Golenbock SW, Lamkin RP, Strymish JM, Harvey K, Yuen K, Schweizer ML, Drekonja D, Rodriguez-Barradas MC, Branch-Elliman W. Leveraging[...]

Emergence of a novel genotype of extensively drug-resistant Shigella sonnei carrying blaDHA-1 in diverse patient populations, Los Angeles, 2024-2025

Gonzalez-Ferrer S, Shaw B, Fung L, Landovitz RJ, Uslan DZ, Yang S. Emergence of a novel genotype of extensively drug-resistant Shigella sonnei carrying blaDHA-1 in diverse patient populations, Los[...]

Parasex generates highly recombinant progeny in Candida albicans with increased virulence

Fillinger RJ, Mishra A, Loza L, Sircaik S, Carriel CC, Mackey AI, Stratton TD, Filler SG, Selmecki AM, Bennett RJ, Anderson MZ. Parasex generates highly[...]